These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22116889)

  • 21. Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
    Pournasr B; Khaloughi K; Salekdeh GH; Totonchi M; Shahbazi E; Baharvand H
    Stem Cells; 2011 Dec; 29(12):1933-41. PubMed ID: 21997905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ID1 and ID3 represent conserved negative regulators of human embryonic and induced pluripotent stem cell hematopoiesis.
    Hong SH; Lee JH; Lee JB; Ji J; Bhatia M
    J Cell Sci; 2011 May; 124(Pt 9):1445-52. PubMed ID: 21486943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gene flaw found in induced stem cells.
    Dolgin E
    Nature; 2010 Apr; 464(7289):663. PubMed ID: 20360708
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hematological diseases and induced pluripotent stem (iPS) cells].
    Kurokawa M
    Rinsho Ketsueki; 2012 Oct; 53(10):1860-4. PubMed ID: 23037762
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro generation of megakaryocytes and platelets from human embryonic stem cells and induced pluripotent stem cells.
    Takayama N; Eto K
    Methods Mol Biol; 2012; 788():205-17. PubMed ID: 22130710
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of induced pluripotent stem cell and embryonic stem cell technology to the study of male infertility.
    Mahabadi JA; Sabzalipour H; Bafrani HH; Gheibi Hayat SM; Nikzad H
    J Cell Physiol; 2018 Nov; 233(11):8441-8449. PubMed ID: 29870061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human pluripotent stem cells for disease modelling and drug screening.
    Maury Y; Gauthier M; Peschanski M; Martinat C
    Bioessays; 2012 Jan; 34(1):61-71. PubMed ID: 22038777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human procreation in unchartered territory: new twists in ethical discussions.
    Ramalho-Santos J
    Hum Reprod; 2011 Jun; 26(6):1284-7. PubMed ID: 21467204
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Turning straw into gold: directing cell fate for regenerative medicine.
    Cohen DE; Melton D
    Nat Rev Genet; 2011 Apr; 12(4):243-52. PubMed ID: 21386864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How far are induced pluripotent stem cells from the clinic?
    Li M; Chen M; Han W; Fu X
    Ageing Res Rev; 2010 Jul; 9(3):257-64. PubMed ID: 20362696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse-induced pluripotent stem cells.
    Zhang H; Jin Y
    Results Probl Cell Differ; 2012; 55():395-411. PubMed ID: 22918817
    [No Abstract]   [Full Text] [Related]  

  • 32. [Neuronal regenerative medicine by using embryonic stem cells].
    Takahashi J
    Masui; 2007 Nov; 56 Suppl():S29-38. PubMed ID: 18051446
    [No Abstract]   [Full Text] [Related]  

  • 33. Generation of male differentiated germ cells from various types of stem cells.
    Hou J; Yang S; Yang H; Liu Y; Liu Y; Hai Y; Chen Z; Guo Y; Gong Y; Gao WQ; Li Z; He Z
    Reproduction; 2014 Jun; 147(6):R179-88. PubMed ID: 24534952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Review of basic studies about the cardiac stem cell and regenerative medicine].
    Tamura Y; Fukuda K
    Nihon Rinsho; 2008 May; 66(5):908-14. PubMed ID: 18464509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. From skin to the treatment of diseases--the possibilities of iPS cell research in dermatology.
    Galach M; Utikal J
    Exp Dermatol; 2011 Jun; 20(6):523-8. PubMed ID: 21585557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Generation of pig induced pluripotent stem cells with a drug-inducible system.
    Wu Z; Chen J; Ren J; Bao L; Liao J; Cui C; Rao L; Li H; Gu Y; Dai H; Zhu H; Teng X; Cheng L; Xiao L
    J Mol Cell Biol; 2009 Oct; 1(1):46-54. PubMed ID: 19502222
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flow cytometric analysis of human pluripotent stem cells.
    Ho MS; Fryga A; Laslett AL
    Methods Mol Biol; 2011; 767():221-30. PubMed ID: 21822878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding the mysteries of iPS cells.
    Cohen JB; Krause DS
    Yale J Biol Med; 2009 Sep; 82(3):105-7. PubMed ID: 19774121
    [No Abstract]   [Full Text] [Related]  

  • 40. iPS cell technology in regenerative medicine.
    Lengner CJ
    Ann N Y Acad Sci; 2010 Mar; 1192():38-44. PubMed ID: 20392216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.